Journal of Surgical Research
Volume 146, Issue 1 , Pages 32-42 , 1 May 2008

Prognostic Values of Matrix Metalloproteinase Family Expression in Human Colorectal Carcinoma

  • Toshimichi Asano, M.D.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • ,
  • Mitsuhiro Tada, M.D., Ph.D.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • ,
  • Shaoqiang Cheng, B.M.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • ,
  • Norihiro Takemoto, M.D.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • ,
  • Taro Kuramae, M.D.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • ,
  • Motoki Abe, M.D., Ph.D.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • ,
  • Osamu Takahashi, M.D.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • ,
  • Masaki Miyamoto, M.D.

      Affiliations

    • Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • ,
  • Jun-Ichi Hamada, Ph.D.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at at Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, N-15 W-7, Kita-Ku, Sapporo 060-0815, Japan.
    • ,
  • Tetsuya Moriuchi, M.D., Ph.D.

      Affiliations

    • Division of Cancer-Related Genes, Institute for Genetic Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan
    • ,
  • Satoshi Kondo, M.D., Ph.D.

      Affiliations

    • Department of Surgical Oncology, Division of Cancer Medicine, Hokkaido University, Graduate School of Medicine, Sapporo, Japan

Received 16 January 2007

References 

  1. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153
  2. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10
  3. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 1991;64:327
  4. Stetler-Stevenson WG, Liotta LA, Kleiner DE. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 1993;7:1434
  5. Zucker S, Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev. 2004;23:101
  6. Stetler-Stevenson WG, Yu AE. Proteases in invasion: Matrix metalloproteinases. Semin Cancer Biol. 2001;11:143
  7. Lambert E, Dasse E, Haye B, et al. TIMPs as multifacial proteins. Crit Rev Oncol Hematol. 2004;49:187
  8. Takahashi C, Sheng Z, Horan TP, et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA. 1998;95:13221
  9. Zeng ZS, Huang Y, Cohen AM, et al. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol. 1996;14:3133
  10. Kikuchi R, Noguchi T, Takeno S, et al. Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma. Br J Cancer. 2000;83:215
  11. Sunami E, Tsuno N, Osada T, et al. MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist. 2000;5:108
  12. Sardinha TC, Nogueras JJ, Xiong H, et al. Membrane-type 1 matrix metalloproteinase mRNA expression in colorectal cancer. Dis Colon Rectum. 2000;43:389
  13. Leeman MF, McKay JA, Murray GI. Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer. J Clin Pathol. 2002;55:758
  14. Ornstein DL, Cohn KH. Balance between activation and inhibition of matrix metalloproteinase-2 (MMP-2) is altered in colorectal tumors compared to normal colonic epithelium. Dig Dis Sci. 2002;47:1821
  15. Zeng ZS, Snu WP, Cohen AM, et al. Matrix metalloproteinase-7 expression in colorectal cancer liver metastasis: Evidence for involvement of MMP-7 activation in human cancer metastasis. Clin Cancer Res. 2002;8:1144
  16. Roeb E, Arndt M, Jansen B, et al. Simultaneous determination of matrix metalloproteinase (MMP)-7, -1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas. Int J Colorectal Dis. 2004;19:518
  17. Skoglund J, Emterling A, Arbman G, et al. Clinicopathological significance of stromelysin-3 expression in colorectal cancer. Oncology. 2004;67:67
  18. Powe DG, Brough JL, Carter GI, et al. TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma. Br J Cancer. 1997;75:1678
  19. Zeng Z, Sun Y, Shu W, et al. Tissue inhibitor of metalloproteinase-3 is a basement membrane-associated protein that is significantly decreased in human colorectal cancer. Dis Colon Rectum. 2001;44:1290
  20. Takeuchi T, Hisanaga M, Nagao M, et al. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. Clin Cancer Res. 2004;10:5572
  21. Dong Z, Kumar R, Yang X, et al. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell. 1997;88:801
  22. Yang W, Arii S, Gorrin-Rivas MJ, et al. Human macrophage metalloelastase gene expression in colorectal carcinoma and its clinicopathologic significance. Cancer. 2001;91:1277
  23. Kinoshita T, Sato H, Okada A, et al. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem. 1998;273:16098
  24. Murashige M, Miyahara M, Shiraishi N, et al. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors. Jpn J Clin Oncol. 1996;26:303
  25. Baker EA, Bergin FG, Leaper DJ. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Br J Surg. 2000;87:1215
  26. Takino T, Sato H, Shinagawa A, et al. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library (MT-MMPs form a unique membrane-type subclass in the MMP family). J Biol Chem. 1995;270:23013
  27. Will H, Hinzmann B. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem. 1995;231:602
  28. Strongin AY, Collier I, Bannikov G, et al. Mechanism of cell surface activation of 72 kDa type IV collagenase. J Biol Chem. 1995;270:5331
  29. Kinoshita T, Sato H, Takino T, et al. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase. Cancer Res. 1996;56:2535
  30. Morrison CJ, Butler GS, Bigg HF, et al. Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway. J Biol Chem. 2001;276:47402
  31. Ueno H, Nakamura H, Inoue M, et al. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res. 1997;57:2055
  32. Gilles C, Polette M, Piette J, et al. High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer. 1996;65:209
  33. Davidson B, Goldberg I, Berner A, et al. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusion. Am J Clin Pathol. 2001;115:517
  34. Abraham R, Schafer J, Rothe M, et al. Identification of MMP-15 as an anti-apoptotic factor in cancer cells. J Biol Chem. 2005;280:34123
  35. Jones LE, Humphreys MJ, Campbell F, et al. Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. Clin Cancer Res. 2004;10:2832
  36. Sato H, Seiki M. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem. 1996;119:209

PII: S0022-4804(07)00069-8

doi: 10.1016/j.jss.2007.02.011

Journal of Surgical Research
Volume 146, Issue 1 , Pages 32-42 , 1 May 2008

Article Tools

* Image Usage & Resolution